Ted started his professional career at Orthovita and reaped on-job-training benefits of a start-up. Ted led the product development collaboration with Kensey Nash Corporation (now DSM Biomedical) who partnered with Orthovita to develop and commercialize Vitoss Foam bone graft substitute with additional handling benefits with bovine collagen. Stryker acquired Orthovita and Ted led the Stryker Orthobiologics Research & Product development team until switching careers at DSM Biomedical in a Commercial role. At DSM, Ted managed commercial relationships and grew his sales for past 5 years. Recently, Ted moved into Strategy and Business Development role and is responsible for capitalizing and executing Specialized Biomaterials Manufacturing opportunities and for extending the DSM Biomedical Innovation team with external partnerships.